Abstract
89 - Prevalence, treatment and outcomes of patients with advanced, non-squamous NSCLC (nsNSCLC) harbouring ALK or ROS1 gene-rearrangements in Dorset
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have